A Systematic Review of Tissue and Single Cell Transcriptome/Proteome Studies of the Brain in Multiple Sclerosis

A Systematic Review of Tissue and Single Cell Transcriptome/Proteome Studies of the Brain in Multiple Sclerosis

Multiple sclerosis (MS) is an inflammatory demyelinating and degenerative disease of the central nervous system (CNS). Although inflammatory responses are efficiently treated, therapies for progression are scarce and suboptimal, and biomarkers to predict the disease course are insufficient. Cure or...

Full description

Bibliographic Details
Main Authors:	Maria L. Elkjaer, Richard Röttger, Jan Baumbach, Zsolt Illes
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-03-01
Series:	Frontiers in Immunology
Subjects:	multiple sclerosis systems biology transcriptome proteome single cell brain lesions
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2022.761225/full

Similar Items

Altered Expression of Ion Channels in White Matter Lesions of Progressive Multiple Sclerosis: What Do We Know About Their Function?
by: Francesca Boscia, et al.
Published: (2021-06-01)

Expression of Bruton´s tyrosine kinase in different type of brain lesions of multiple sclerosis patients and during experimental demyelination
by: Maria L. Elkjaer, et al.
Published: (2023-11-01)

Molecular signature of different lesion types in the brain white matter of patients with progressive multiple sclerosis
by: Maria L. Elkjaer, et al.
Published: (2019-12-01)

RETRACTED ARTICLE: Unique RNA signature of different lesion types in the brain white matter in progressive multiple sclerosis
by: Maria L. Elkjaer, et al.
Published: (2019-04-01)

Absence of miRNA-146a Differentially Alters Microglia Function and Proteome
by: Nellie A. Martin, et al.
Published: (2020-06-01)

Hypothesis of a potential BrainBiota and its relation to CNS autoimmune inflammation
by: Maria L. Elkjaer, et al.
Published: (2022-12-01)

Editorial: Multiple Sclerosis – From Bench to Bedside: Currents Insights Into Pathophysiological Concepts and Their Potential Impact on Patients
by: Paulus S. Rommer, et al.
Published: (2020-02-01)

Hypothesis of a potential BrainBiota and its relation to CNS autoimmune inflammation
by: Elkjaer, Maria L., et al.
Published: (2023)

Retraction Note: Unique RNA signature of different lesion types in the brain white matter in progressive multiple sclerosis
by: Maria L. Elkjaer, et al.
Published: (2019-08-01)

CSF proteome in multiple sclerosis subtypes related to brain lesion transcriptomes
by: Maria L. Elkjaer, et al.
Published: (2021-02-01)

Longitudinal analysis of peripheral immune cells in patients with multiple sclerosis treated with anti‐CD20 therapy
by: Mie Waede, et al.
Published: (2024-10-01)

Functional enrichment of alternative splicing events with NEASE reveals insights into tissue identity and diseases
by: Zakaria Louadi, et al.
Published: (2021-12-01)

Quantifying brain tissue volume in multiple sclerosis with automated lesion segmentation and filling
by: Sergi Valverde, et al.
Published: (2015-01-01)

Treatment of relapsing multiple sclerosis in Hungary – consensus recommendation from the Hungarian neuroimmunology society
by: Cecilia Rajda, et al.
Published: (2023-07-01)

Investigation of multiple sclerosis-related pathways through the integration of genomic and proteomic data
by: Elif Everest, et al.
Published: (2021-09-01)

Proteomic changes during experimental de- and remyelination in the corpus callosum.
by: Gabor T Szilagyi, et al.
Published: (2020-01-01)

Clinical application of Bender–Gestalt in screening of brain lesions in patients with Stroke and Multiple Sclerosis
by: Maryam Zanjani, et al.
Published: (2017-12-01)

Central Nervous System Proteomics in Animal Model of Multiple Sclerosis Revealed Down-Regulation of Mithochondrial Proteins
by: Abolhassan Shahzadeh Fazeli, et al.
Published: (2009-01-01)

Multiple sclerosis: 2023 update
by: Tanja Kuhlmann, et al.
Published: (2023-03-01)

Integrated analysis of plasma proteome and cortex single-cell transcriptome reveals the novel biomarkers during cortical aging
by: Rui-Ze Niu, et al.
Published: (2023-07-01)

A contrast-adaptive method for simultaneous whole-brain and lesion segmentation in multiple sclerosis
by: Stefano Cerri, et al.
Published: (2021-01-01)

Vasomotor reactivity comparison in multiple sclerosis patients with white matter lesions and nonmultiple sclerosis subjects with white matter lesions in brain magnetic resonance imaging
by: Fariborz Khorvash, et al.
Published: (2016-01-01)

Patient Attitudes to Routine Cognitive Testing in Multiple Sclerosis
by: Mortensen GL, et al.
Published: (2020-04-01)

Typical MRI lesions of multiple sclerosis in the brain and spinal cord (ORP-13)
by: Zahra Hamed
Published: (2023-01-01)

Case Report: A Case of Severe Clinical Deterioration in a Patient With Multiple Sclerosis
by: Katharina Breitkopf, et al.
Published: (2020-08-01)

Brain Citrullination Patterns and T Cell Reactivity of Cerebrospinal Fluid-Derived CD4+ T Cells in Multiple Sclerosis
by: Wolfgang Faigle, et al.
Published: (2019-04-01)

Identification of potential drug targets for amyotrophic lateral sclerosis by Mendelian randomization analysis based on brain and plasma proteomics
by: Ni Yang, et al.
Published: (2024-10-01)

High-Resolution Transcriptomic and Proteomic Profiling of Heterogeneity of Brain-Derived Microglia in Multiple Sclerosis
by: Anneke Miedema, et al.
Published: (2020-10-01)

A white matter lesion-filling approach to improve brain tissue volume measurements
by: Sergi Valverde, et al.
Published: (2014-01-01)

Immunological Aspects of Approved MS Therapeutics
by: Paulus S. Rommer, et al.
Published: (2019-07-01)

A comparison of brain magnetic resonance imaging lesions in multiple sclerosis by race with reference to disability progression
by: Yuri Nakamura, et al.
Published: (2018-09-01)

Automatic segmentation and volumetry of multiple sclerosis brain lesions from MR images
by: Saurabh Jain, et al.
Published: (2015-01-01)

Omics approaches to understanding the efficacy and safety of disease-modifying treatments in multiple sclerosis
by: Lorena Lorefice, et al.
Published: (2023-01-01)

Erratum: Omics approaches to understanding the efficacy and safety of disease-modifying treatments in multiple sclerosis
by: Frontiers Production Office
Published: (2023-03-01)

A Systematic Review of Quantitative MRI Brain Analysis Studies in Multiple Sclerosis Disease
by: Andria Nicolaou, et al.
Published: (2024-01-01)

Identification of Four Biomarkers of Human Skin Aging by Comprehensive Single Cell Transcriptome, Transcriptome, and Proteomics
by: Rui Mao, et al.
Published: (2022-08-01)

LesionQuant for Assessment of MRI in Multiple Sclerosis—A Promising Supplement to the Visual Scan Inspection
by: Synne Brune, et al.
Published: (2020-12-01)

Integration of single‐cell transcriptome and proteome technologies: Toward spatial resolution levels
by: Liyong He, et al.
Published: (2023-10-01)

Circulating microRNAs correlate with structural and functional MRI parameters in patients with multiple sclerosis
by: Lili Geiger, et al.
Published: (2023-10-01)

No Plasmatic Proteomic Signature at Clinical Disease Onset Associated With 11 Year Clinical, Cognitive and MRI Outcomes in Relapsing-Remitting Multiple Sclerosis Patients
by: Claire Bridel, et al.
Published: (2018-10-01)